Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 983

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 7A
Chunk 983
---
572,415 

    Year Ended March 31, 2025  
    Year Ended March 31, 2024 
  
    Weighted-average grant date fair value of: 

    Non-vested options, beginning of period 
    $1.84  
    $2.23 
  
    Non-vested options, end of period 
    $0.80  
    $1.84 
  
    Vested options, end of period 
    $1.06  
    $2.21 
  
    Forfeited options, during the period 
    $-  
    $2.03 

Warrants

During
the year ended March 31, 2025, the Company issued warrants to purchase an aggregate of 7,110,232 shares of common stock as follows:

    i)
    430,798 warrants
    in April 2024 in connection with the conversion of convertible debentures to common stock valued at $96,456;
  
    ii)
    1,889,434 warrants in May
    2024 in connection with the sale of stock in a private offering;
  
    iii)
    3,045,000 warrants in July
    2024 in connection with the sale of Series A preferred stock in a private offering;
  
    iv)
    250,000 warrants in February
    and March 2025 in connection with the purchase of an exclusive license agreement with VetStem; fair value of $46,030;
  
    v)
    1,000,000 warrants in February 2025 in connection with
    the investment in Digital Landia fair valued at $35,197;
  
    vi)
    250,000 warrants in February 2025 in connection with two investors who put in $500,000 in a short term convertible
note;
  
    vii)
    150,000 warrants in February and March 2025 to a board member who put in $300,000 proceeds for a short-term promissory
note;
  
    viii)
    95,000
    warrants in March 2025 to a service provider fair valued at $15,775

During
the year ended March 31, 2024 the Company issued warrants to purchase an aggregate of 4,386,463 shares of common stock as follows:

    i)
    1,200,002 warrants
    in August 2023 in connection